Moira C. Graves
University Dr
Callaghan, NSW 2308, Australia
Callaghan, NSW 2308, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
ATR inhibition using gartisertib enhances cell death and synergises with temozolomide and radiation in patient-derived glioblastoma cell lines.
Journal: Oncotarget
Published: January 16, 2024
Vasculogenic Mimicry Occurs at Low Levels in Primary and Recurrent Glioblastoma.
Journal: Cancers
Published: July 06, 2023
Characteristics of vasculogenic mimicry and tumour to endothelial transdifferentiation in human glioblastoma: a systematic review.
Journal: BMC cancer
Published: October 31, 2022
Melanoma: An immunotherapy journey from bench to bedside.
Journal: Cancer treatment and research
Published: May 13, 2022
Repurposing Azacitidine and Carboplatin to Prime Immune Checkpoint Blockade-resistant Melanoma for Anti-PD-L1 Rechallenge.
Journal: Cancer research communications
Published: May 09, 2022
Transcriptomic Profiling of DNA Damage Response in Patient-Derived Glioblastoma Cells before and after Radiation and Temozolomide Treatment.
Journal: Cells
Published: March 09, 2022
Low tumour-infiltrating lymphocyte density in primary and recurrent glioblastoma.
Journal: Oncotarget
Published: July 01, 2021
Overall survival in metastatic melanoma correlates with pembrolizumab exposure and T cell exhaustion markers.
Journal: Pharmacology research & perspectives
Published: March 23, 2021
DNA damage repair in glioblastoma: current perspectives on its role in tumour progression, treatment resistance and PIKKing potential therapeutic targets.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: December 21, 2020
Pilot early phase II study of decitabine and carboplatin in patients with advanced melanoma.
Journal: Medicine
Published: June 23, 2020
Immune checkpoint blockade in solid organ tumours: Choice, dose and predictors of response.
Journal: British journal of clinical pharmacology
Published: October 29, 2019
Monitoring Patient Response to Pembrolizumab With Peripheral Blood Exhaustion Marker Profiles.
Journal: Frontiers in medicine
Published: September 03, 2018
Last Updated: 09/26/2026